Loukas Settas
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies 10
- Systemic Lupus Erythematosus Research 9
- Spondyloarthritis Studies and Treatments 3
- Hematology top 2%
- Autoimmune and Inflammatory Disorders Research 4
- Immunology top 10%
-
- Systemic Sclerosis and Related Diseases 10
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 3
-
- Pulmonary Hypertension Research and Treatments 5
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
- Co-authors
- Paul EmeryMaxime DougadosMichel MalaiseMartin KaulH. KüpperJ. W. J. BijlsmaS TodescoCatherine Atkin
- Cited by
- RheumatologyHematologyImmunology
- Journals
- The Journal of Rheumatology (3 papers)Clinical Rheumatology (3 papers)Annals of the Rheumatic Diseases (2 papers)
- Partner nations
- GreeceUnited KingdomUnited States
In The Last Decade
Loukas Settas
27 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Rheumatology 819
- Hematology 358
- Immunology 349
- Pathology and Forensic Medicine 255
- Genetics 134
Countries citing papers authored by Loukas Settas
This map shows the geographic impact of Loukas Settas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loukas Settas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loukas Settas more than expected).
Fields of papers citing papers by Loukas Settas
This network shows the impact of papers produced by Loukas Settas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loukas Settas. The network helps show where Loukas Settas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Loukas Settas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 1 | |
| 3 | 2022 | 5 | |
| 4 | 2019 | 5 | |
| 5 | 2018 | 34 | |
| 6 | Safety profile of repeated rituximab cycles in unselected rheumatoid arthritis patients: a long-term, prospective real-life study. | 2017 | 21 |
| 7 | Treatment with the first TNF inhibitor in rheumatoid arthritis patients in the Hellenic Registry of Biologic Therapies improves quality of life especially in young patients with better baseline functional status. | 2017 | 7 |
| 8 | 2017 | 9 | |
| 9 | 2016 | 42 | |
| 10 | Clinical expression and course in patients with late onset systemic lupus erythematosus. | 2013 | 24 |
| 11 | 2013 | 8 | |
| 12 | 2011 | 1 | |
| 13 | 2011 | 8 | |
| 14 | 2010 | 43 | |
| 15 | 2010 | 32 | |
| 16 | 2009 | 38 | |
| 17 | 2008 | 45 | |
| 18 | 2008 | 12 | |
| 19 | Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failedbreakdown → | 2004 | 512 |
| 20 | 1989 | 57 |
About Loukas Settas
Loukas Settas is a scholar working on Rheumatology, Pathology and Forensic Medicine, Hematology, Immunology and Genetics, having authored 28 papers that have together received 1.2k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (10 papers), Systemic Sclerosis and Related Diseases (10 papers), Systemic Lupus Erythematosus Research (9 papers), Pulmonary Hypertension Research and Treatments (5 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Spondyloarthritis Studies and Treatments (3 papers). The work is most often cited by research in Rheumatology (819 citations), Hematology (358 citations), Immunology (349 citations), Pathology and Forensic Medicine (255 citations) and Genetics (134 citations). Loukas Settas has collaborated with scholars based in Greece, United Kingdom and United States. Frequent co-authors include Paul Emery, Maxime Dougados, Michel Malaise, Martin Kaul, H. Küpper, J. W. J. Bijlsma, S Todesco, Catherine Atkin, Anthony S. Russell and Steven Fischkoff. Their work appears in journals such as The Journal of Rheumatology, Clinical Rheumatology, Annals of the Rheumatic Diseases, Seminars in Arthritis and Rheumatism and Postgraduate Medical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.